These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6783575)

  • 1. Platelet function and fibrinolytic activity after a single dose of diflunisal (Donobid).
    Stenbjerg S; Petersen JK
    Int J Oral Surg; 1980 Dec; 9(6):472-6. PubMed ID: 6783575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation in patients treated with diflunisal.
    Ghosh ML; Tingle A
    Curr Med Res Opin; 1980; 6(7):510-2. PubMed ID: 7363651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic activity after administration of diflunisal and aspirin. A double-blind, randomized, placebo-controlled clinical trial.
    Green D; Davies RO; Holmes GI; Johnson C; Kohl H; Reynolds N; Ts'ao C
    Haemostasis; 1983; 13(6):394-8. PubMed ID: 6365701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of diflunisal administration on platelet aggregation and cerebral blood flow.
    Mikhailidis DP; Barradas MA; Temple-Savage I; Streete PJ; Henry JA; James IM; Dandona P
    Pharmatherapeutica; 1985; 4(4):255-9. PubMed ID: 4059301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of diflunisal on bleeding time and platelet aggregation in a multidose study.
    Chapman PJ; Macleod AW
    Int J Oral Maxillofac Surg; 1987 Aug; 16(4):448-53. PubMed ID: 3117918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diflunisal on platelet function and fecal blood loss.
    Green D; Davies RO; Holmes GI; Kohl H; Lee RB; Reynolds N; Schmid FR; Ts'ao C
    Clin Pharmacol Ther; 1981 Sep; 30(3):378-84. PubMed ID: 6974077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation.
    Nitelius E; Brantmark B; Fredholm B; Hedner U; Forshell GP; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1984; 27(2):165-8. PubMed ID: 6499897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diflunisal on in vitro platelet aggregation.
    Mikhailidis DP; Freedman DB; Dandona P
    Lancet; 1980 Jul; 2(8187):215. PubMed ID: 6105389
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
    Legnani C; Frascaro M; Guazzaloca G; Ludovici S; Cesarano G; Coccheri S
    Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piretanide: a new synthetic fibrinolytic and anti-platelet agent.
    Chohan IS
    Thromb Haemost; 1986 Dec; 56(3):360-3. PubMed ID: 3563967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylate inhibition of antiplatelet effect of aspirin.
    Brantmark B; Hedner U; Melander A; Wåhlin-Boll E
    Lancet; 1981 Dec; 2(8259):1349. PubMed ID: 6118746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of thrombocyte aggregation in altering the fibrinolytic activity and nonenzymatic fibrinolysis of the blood plasma].
    Pastorova VE; Bazaz'ian GG; Romanovskiĭ AA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (8):58-61. PubMed ID: 6215958
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
    Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
    Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyproterone acetate on platelet aggregability, fibrinolytic activity and fibrinolytic capacity in normal men.
    Føgh M; Knudsen JB; Gormsen J
    Acta Endocrinol (Copenh); 1980 Jul; 94(3):430-2. PubMed ID: 6999825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function and fibrinolytic activity following distance running.
    Knudsen JB; Brodthagen U; Gormsen J; Jordal R; Nørregaard-Hansen K; Paulev PE
    Scand J Haematol; 1982 Nov; 29(5):425-30. PubMed ID: 7156892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effects of low molecular weight heparan sulphate on the human fibrinolytic enzyme system.
    Marsh NA; Born GV
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):453-8. PubMed ID: 1932531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of primary hemostasis and platelet function after alcohol ingestion in man.
    Elmér O; Göransson G; Zoucas E
    Haemostasis; 1984; 14(2):223-8. PubMed ID: 6735279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
    Basista M; Grodzińska L; Swies J
    Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ageing on platelet function and fibrinolytic activity.
    Gleerup G; Winther K
    Angiology; 1995 Aug; 46(8):715-8. PubMed ID: 7639418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.